Clinical trial
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up
NCT01888835 is registered in ClinicalTrials.gov with Phillip Coffin, MD, MIA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up
- Lead sponsor
- Phillip Coffin, MD, MIA
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- October 31, 2017
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.